Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2024, Vol. 20 ›› Issue (05): 556 -563. doi: 10.3877/cma.j.issn.1673-5250.2024.05.012

Special Issue:

Special Column of Frontiers in Obstetrics

Pregnancy complicated with thrombotic thrombocytopenic purpura:two cases report and literature review

Jiangyan Xie1,2,3, Yafei Wang4, Fang He1,2,()   

  1. 1.Department of Obstetrics and Gynecology,Guangdong Provincial Key Laboratory of Obstetrics Diseases,Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine,Guangdong Engineering and Technology Research Center for Maternal-Fetal Medicine,The Third Affiliated Hospital,Guangzhou Medical University,Guangzhou 510150,Guangdong Province,China
    2.Guangdong Provincial Clinical Research Center of Obstetrics and Gynecology,The Third Affiliated Hospital,Guangzhou Medical University,Guangzhou 510120,Guangdong Province,China
    3.Department of Obstetrics,Hainan Women and Children Medical Center,Haikou 570206,Hainan Province,China
    4.Department of Obstetrics,Guiyang Second People's Hospital,Guiyang 550005,Guizhou Province,China
  • Received:2024-08-25 Revised:2024-09-15 Published:2024-10-01
  • Corresponding author: Fang He

Objective

To explore the diagnosis and treatment of pregnancy complicated with thrombotic thrombocytopenic purpura (TTP).

Methods

Two cases of pregnancy complicated with TTP admitted to the Third Affiliated Hospital of Guangzhou Medical University on September 3,2022,and February 17,2024(patient 1 and patient 2)were selected as the subjects of this study.A retrospective analysis of their clinical characteristics,laboratory test results,diagnosis and treatment processes,and outcomes was conducted.Additionally,literature related to TTP in pregnancy from domestic and international databases was searched to summarize the clinical manifestations,diagnosis,and treatment of pregnancy complicated with TTP.The procedures followed in this study complied with the requirements of the 2013 revision of the WorldMedicalAssociationDeclarationofHelsinki.

Results

①patient 1 was admitted due to"amenorrhea at 36+3 weeks,both lower limb edema for 2 weeks,and elevated blood pressure for 2 days",with a history of systemic lupus erythematosus(SLE).At 36+3 weeks of gestation,she developed severe decrease of platelet count(PLT)and hemolytic anemia,which led to the consideration of"lupus crisis",then an emergency cesarean section was performed.According to the activity of ADAMTS13 was measured to be 0.1%,patient 1 was confirmed the diagnosis of SLE complicated with TTP.After platelet transfusion,red blood cell transfusion,plasma exchange,and corticosteroid therapy for patient 1,she was successfully treated.②Patient 2 was admitted due to"elevated liver enzymes and thrombocytopenia for 6+h after cesarean section".At 36+4 weeks of gestation,she underwent an emergency cesarean section due to severe preeclampsia (sPE).Postoperatively,she experienced a decrease in PLT and an increase in liver enzymes,suspected to have hemolysis,elevated liver enzymes,low platelet count(HELLP)syndrome.Subsequently,the PLT further decreased,accompanied by h emolytic anemia.According to the activity and inhibitor of ADAMTS13 test results,a diagnosis of TTP was confirmed of patient 2.Patient 2 was discharged after plasma exchange,blood product transfusion,and blood purification therapy,and her renal function returned to normal after a 1-month follow-up.③A search conducted according to the literature search strategy set in this study showed a total of 97 pieces of literature about pregnancy complicated with TTP,including 125 cases of pregnancy complicated with TTP,and plus 2 cases (patient 1 and patient 2),there were 127 cases of pregnancy complicated with TTP.The analysis of case data of 127 cases showed that 63 cases (49.6%)presented with the TTP triad,and 8 cases (6.3%)presented with the TTP pentad;58 cases (45.7%)underwent ADAMTS13 activity testing,with 48 cases (82.8%)showing severe reduction in activity;100 cases (78.7%)underwent plasma exchange treatment,with 25 cases (25.0%)resulting in death,and among the 27 cases(21.3%)who did not receive plasma exchange treatment,12 cases (44.4%)resulting in death.

Conclusions

Pregnancy is one of the triggers for TTP in pregnant women,and pregnant women with clinical manifestations of microangiopathic hemolytic anemia (MAHA)and thrombocytopenia should be vigilant about this disease.ADAMTS13 activity t esting aids in the diagnosis of TTP.Plasma exchange is an effective treatment measure for pregnant women with TTP after delivery.

图1 患者1(女性,35岁)本次病程血液指标变化趋势及主要治疗策略 注:患者1临床诊断为SLE 合并TTP。SLE 为系统性红斑狼疮,TTP为血栓性血小板减少性紫癜。WBC 为白细胞计数,Hb为血红蛋白,PLT 为血小板计数,ICU 为重症监护病房。输血小板:9月2、4日各2个治疗量,9月3、5、7日各1个治疗量;输悬浮红细胞:9月2、3、5、7、10、11日各2 U,9月4日4 U
图2 患者2(女性,31岁)本次病程WBC、Hb、PLT 变化趋势及主要治疗策略 注:患者2被临床诊断为TTP。TTP为血栓性血小板减少性紫癜。WBC为白细胞计数,Hb为血红蛋白,PLT 为血小板计数,ICU 为重症监护病房。2月16日外院住院及剖宫产,2月17日转本院及ICU,3月9日出院。输新鲜冰冻血浆:2月17日外院400 m L、转本院后400 m L,2月18、19、22日各200 m L;输悬浮红细胞:2月17日转本院后、18日、22日各2 U;输洗涤红细胞:2月19、20日各2 U
图3 患者2(女性,31岁)本次病程ALT、肌酐变化趋势及主要治疗策略 注:患者2被临床诊断为TTP。TTP为血栓性血小板减少性紫癜,ALT 为丙氨酸转氨酶
表1 妊娠相关TMA 类疾病及AFLP的临床表现和实验室检查特点比较
[1]
Fakhouri F.Pregnancy-related thrombotic microangiopathies:clues from complement biology[J].Transfus Apher Sci,2016,54(2):199-202.DOI:10.1016/j.transci.2016.04.009.
[2]
Kappler S,Ronan-Bentle S,Graham A.Thrombotic microangiopathies(TTP,HUS,HELLP)[J].Hematol Oncol Clin North Am,2017,31(6):1081-1103.DOI:10.1016/j.hoc.2017.08.010.
[3]
殷杰,余自强.《血栓性血小板减少性紫癜诊断与治疗中国指南(2022年版)》解读[J].中华血液学杂志,2022,43(1):16-18.DOI:10.3760/cma.j.issn.0253-2727.2022.01.004.Yin J,Yu ZQ.Interpretation of Chineseguidelineonthe diagnosisandmanagementofthromboticthrombocytopenic purpura2022)[J].Chin J Hematol,2022,43(1):16-18.DOI:10.3760/cma.j.issn.0253-2727.2022.01.004.
[4]
中华医学会血液学分会血栓与止血学组.血栓性血小板减少性紫癜诊断与治疗中国指南(2022年版)[J].中华血液学杂志,2022,43(1):7-12.DOI:10.3760/cma.j.issn.0253-2727.2022.01.002.Thrombosis and Hemostasis Group,Hematology Branch,Chinese Medical Association.Chinese guideline on the diagnosis and management of thrombotic thrombocytopenic purpura (2022)[J].Chin J Hematol,2022,43(1):7-12.DOI:10.3760/cma.j.issn.0253-2727.2022.01.002.
[5]
Miodownik S,Pikovsky O,Erez O,et al.Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy:lessons from a cluster of familial cases[J].Am J Obstet Gynecol,2021,225(2):177.e1-177177.e15.DOI:10.1016/j.ajog.2021.02.018.
[6]
Brown J,Potugari B,Mazepa MA,et al.Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immunemediated thrombotic thrombocytopenic purpura[J].Ann Hematol,2022,101(10):2159-2167.DOI:10.1007/s00277-022-04936-2.
[7]
Kremer Hovinga JA,George JN.Hereditary thrombotic thrombocytopenic purpura[J].N Engl J Med,2019,381(17):1653-1662.DOI:10.1056/NEJMra1813013.
[8]
Nonaka T,Yamaguchi M,Nishijima K,et al.A successfully treated case of an acute presentation of congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)with decreased ADAMTS13 during late stage of pregnancy[J].J Obstet Gynaecol Res,2021,47(5):1892-1897.DOI:10.1111/jog.14737.
[9]
Rottenstreich A,Dor S,Keren-Politansky A,et al.Pregnancy and non-pregnancy related immune thrombotic thrombocytopenic purpura in women of reproductive age[J].J Thromb Thrombolysis,2021,51(1):187-193.DOI:10.1007/s11239-020-02133-4.
[10]
Lim MY,Abou-Ismail MY,Branch DW.Differentiating and managing rare thrombotic microangiopathies during pregnancy and postpartum[J].Obstet Gynecol,2023,141(1):85-108.DOI:10.1097/AOG.0000000000005024.
[11]
Gerth J,Schleussner E,Kentouche K,et al.Pregnancyassociated thrombotic thrombocytopenic purpura [J].Thromb Haemost,2009,101(2):248-251.
[12]
Scully M,Rayment R,Clark A,et al.A british society for haematology guideline:diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies[J].Br J Haematol,2023,203(4):546-563.DOI:10.1111/bjh.19026.
[13]
Gavriilaki E,Anagnostopoulos A,Mastellos DC.Complement in thrombotic microangiopathies:unraveling Ariadne's thread into the labyrinth of complement therapeutics[J].Front Immunol,2019,10:337.DOI:10.3389/fimmu.2019.00337.
[14]
Giannubilo SR,Marzioni D,Tossetta G,et al.HELLP syndrome and differential diagnosis with other thrombotic microangiopathies in pregnancy[J].Diagnostics (Basel),2024,14(4):352.DOI:10.3390/diagnostics14040352.
[15]
Hugenholtz GC,Adelmeijer J,Meijers JC,et al.An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure:implications for hemostasis and clinical outcome[J].Hepatology,2013,58(2):752-761.DOI:10.1002/hep.26372.
[16]
刘从丽,陈敦金,陈楚仪,等.妊娠期急性脂肪肝86例临床分析[J].中华妇产科杂志,2023,58(12):896-902.DOI:10.3760/cma.j.cn112141-20230814-00047.Liu CL,Chen DJ,Chen CY,et al.Clinical analysis of 86 cases of acute fatty liver of pregnancy[J].Chin J Obstet Gynecol,2023,58(12):896-902.DOI:10.3760/cma.j.cn112141-20230814-00047.
[17]
Dap M,Romiti J,Dolenc B,et al.Thrombotic thrombocytopenic purpura and severe preeclampsia:a clinical overlap during pregnancy and a possible coexistence[J].J Gynecol Obstet Hum Reprod,2022,51(7):102422.DOI:10.1016/j.jogoh.2022.102422.
[18]
Martin JN Jr,Tucker JM.Maternal morbidity and mortality in pregnant/postpartum women with suspected HELLP syndrome identifiable as probable thrombotic thrombocytopenic purpura or atypical hemolytic uremic syndrome by high LDH to AST ratio[J].Int J Gynaecol Obstet,2022,159(3):870-874.DOI:10.1002/ijgo.14177.
[19]
Zheng XL.The standard of care for immune thrombotic thrombocytopenic purpura today[J].J Thromb Haemost,2021,19(8):1864-1871.DOI:10.1111/jth.15406.
[20]
杨勇,周玮.妊娠期血栓性血小板减少性紫癜和溶血性尿毒症综合征的识别与治疗[J].中国实用妇科与产科杂志,2022,38(12):1173-1177.DOI:10.19538/j.fk2022120107.Yang Y,Zhou W.Identification and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy[J].Chin J Pract Gynecol Obstet,2022,38(12):1173-1177.DOI:10.19538/j.fk2022120107.
[1] Qianmei Li, Guannan He, Jing Zhao, Xi Chen, Yuying Tang, Liqiong Ma, Rong Liang, Tao Yuan, Mingxing Li. Placental microvascular flow imaging characteristics and prognosis of early low-risk and high-risk pregnancies[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 726-732.
[2] Jingyu Qian, Mingming Zheng. Interpretation of the Italian guidelines on non-invasive and invasive prenatal diagnosis:executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology(SIGO)[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 486-492.
[3] Xialin Li, Fang He. Risk assessment and early warning system for postpartum hemorrhage[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 498-503.
[4] Ziyang Liu, Jianjian Cui, Yin Zhao. Current research status on obstetric disseminated intravascular coagulation and its scoring system[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 511-518.
[5] Fanying Zeng, Jie Ruan, Xinghui Liu, Guolin He. Current status of perinatal medicine advances under the new reproductive situation and coping strategies in prenatal care[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 519-524.
[6] Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[7] Rong Huang, Ziyu Liang, Wenjin Qi. Expression and significance of NLRP3 inflammasome in serum of pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 540-548.
[8] Xia He, Rong Huang, Wenjin Qi. High-throughput sequencing study on the abundance of placenta and fetal membrane flora in pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 549-555.
[9] Xiaoyan Han, Hua Yang. Relationship between low level of serum placental growth factor in the second trimester pregnancy women and adverse fetal prognosis[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 398-402.
[10] Jiali Du, Rui Bao, Chunhong Qiao, Wei Han. Construction of a prediction model for adverse pregnancy outcomes after emergency cervical cerclage in pregnant women with cervical incompetence during the second trimester[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 403-409.
[11] Jing Zhang, Chang Liu, Chengge Hua. Progress in the treatment of oral diseases during pregnancy[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2024, 18(05): 340-344.
[12] Jingyun Xu, Bo Ding, Yuhui Jiang, Yang Shen. The practice and consideration of single-site laparoscopic operation during pregnancy[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2024, 17(05): 262-266.
[13] Xiaojing Hu, Hua Zhang. Diagnosis and treatment of ovarian cyst torsion during pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(04): 197-201.
[14] Pu Li, Xiujie Sheng. Management of pregnancy complicated with cervical cancer[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(04): 202-208.
[15] Zhongxia Hang, Zhaoxia Wang, Qin Sun, Ni Li. The application of serum Irisin,TSH and Hcy in diagnosing gestational hypothyroidism[J]. Chinese Journal of Diagnostics(Electronic Edition), 2024, 12(04): 265-269.
Viewed
Full text


Abstract